#USA #New York #Securities Fraud #Rosen Law Firm #Geron Corporation

Geron Corporation Securities Fraud Lawsuit: An Opportunity for Investors

In the wake of serious allegations regarding securities fraud, investors who purchased securities of Geron Corporation (NASDAQ: GERN) between February 28, 2024, and February 25, 2025, are reminded of their opportunity to join a class action lawsuit. The Rosen Law Firm, a reputable global investor rights law firm, has been vocal about the case and encourages affected investors to take action.

Key Information Regarding the Class Action

Important Deadline

The law firm has specified May 12, 2025, as the critical deadline for those who wish to assume the role of lead plaintiff in the lawsuit. A lead plaintiff is crucial for directing the course of litigation on behalf of other affected investors.

Who Is Eligible?

If you acquired Geron securities during the designated timeframe, you could be entitled to compensation without any upfront costs. This is facilitated through a contingency fee arrangement, meaning that legal fees are only paid if a successful recovery is made in the lawsuit.

How to Participate

Interested parties can easily join the class action by visiting Rosen Legal's website. Additionally, for further questions, Phillip Kim, an attorney at the firm, can be contacted toll-free at 866-767-3653 or via email at [email protected].

Background of the Case

The securities fraud allegations stem from claims that Geron Corporation misrepresented crucial information regarding its product, RYTELO. It has been alleged that the company’s representatives made misleading statements and failed to disclose significant risks associated with the product’s market viability. Specifically, the lawsuit outlines that:

• - There was a lack of awareness among healthcare providers regarding RYTELO, directly contrary to claims made by Geron.
• - Existing competition along with seasonal impacts would limit the product's market performance, making the anticipated profits overvalued.
• - Consequently, the company's financial prospects were grossly overstated, leading to misleading public statements.

These misleading assertions have caused investors to suffer damages when factual information eventually came to light, adversely affecting the company's stock performance.

Selecting the Right Legal Representation

Rosen Law Firm stresses the importance of choosing qualified legal counsel with a successful history in securities class actions. Many firms might not possess the necessary experience or resources to effectively handle such cases. Rosen Law Firm has established itself as a leader in this field, having secured some of the largest securities settlements, including notable claims against foreign corporations.

In 2019 and beyond, the firm has been recognized for recovering substantial amounts for investors, underscoring its commitment to fighting for investor rights. In addition, its founding partner, Laurence Rosen, has garnered extensive accolades within the legal community, further establishing the firm’s credibility.

The Path Forward

Potential plaintiffs are encouraged to act quickly due to the May 12 deadline looming ahead. Although an official class has not been certified yet, joining the suit may be crucial for anyone invested in Geron Corporation during the specified period.

For those who prefer to remain as absent class members, do note that your ability to partake in any potential future recovery does not mandate a role as lead plaintiff. It is essential to be informed and prepared, as developments within the case may evolve substantially leading up to the deadline.

In conclusion, investors of Geron Corporation have an important decision to make regarding their potential compensation related to this ongoing lawsuit. Those interested should not hesitate to reach out to the Rosen Law Firm for further guidance and information on how best to proceed.